MOXISYLYTE
MOXISYLYTE
- CAS:
- 54-32-0
- MF:
- C16H25NO3
- MW:
- 279.37
Suppliers by country/region
Company Type
Properties
- storage temp.
- 2-8°C
Safety Information
- Symbol(GHS)
GHS07
- Signal word
- Warning
- Hazard statements
- H302-H315-H319-H335
- Precautionary statements
- P261-P305+P351+P338
Use
Moxisylyte was introduced in the late 1980s. It belongs to the group of a-adrenergic blocking agents. In France it is indicated for the treatment of manifestations of benign prostatic hypertrophy. It is also marketed in the UK at lower dosages for the treatment of peripheral vascular disorders (Raynaud's disease).
0 India supplier list of "MOXISYLYTE"
- Product Name:Moxisylyte
- Products Intro:Brand:pharmaffiliates | Product Number:PA4056000
- Company Type: Trader
- Country/Region: INDIA
-
1g$608.00
- Product Name:4-(2-(Dimethylamino)ethoxy)-5-isopropyl-2-methylphenylacetate
- Products Intro:Brand:Crysdot | Product Number:CD12062995 | Purity:95+%
- Company Type: Trader
- Country/Region: UNITED STATES
-
5MG$501.041G$1124.55
- Product Name:MOXISYLYTE
- Products Intro:Brand:Acccorporation | OriginalID:API0008715 | Purity:95.00%
- Company Type: Trader
- Country/Region: UNITED STATES